Omoruyi Osula, PhD is a registered patent agent who focuses on patent preparation and prosecution in the chemical, pharmaceutical, and biotechnology arts. Omoruyi also conducts non-infringement, due diligence and patent landscape analyses, as well as legal opinions. His areas of expertise include pharmaceutical formulations, medical devices, antibody-based anti-cancer drugs, mass spectrometry, proteomics, and chromatography-based protein separation.
Omoruyi’s doctoral research focused on developing mass spectrometry and protein cleavage-based methods for the improved identification of post-translationally modified mitotic proteins. This work led to two awards, two articles published in peer-reviewed journals, and afforded opportunities to present at international conferences. Prior to joining Wood IP, Omoruyi spent several years as a patent agent with Sterne Kessler Goldstein & Fox.
Johns Hopkins University School of Medicine
Ph.D., Pharmacology, 2012
B.S., Biology, 2004, magna cum laude, Phi Beta Kappa
United States Patent and Trademark Office
- Osula, O.; Stephen, S.; Cotter, R.J. Identification of protein SUMOylation sites by mass spectrometry using combined microwave-assisted aspartic acid cleavage and tryptic digestion. Journal of Mass Spectrometry. 2012, 47, 644-654.
- Cubenas-Potts, C.; Srikumar, T.; Lee, C.; Osula, O.; Subramonian, D., Zhang, X.-D., Cotter, R.J., Raught, B. and Matunis, M.J. Identification of SUMO2/3 modified proteins associated with mitotic chromosomes. Proteomics. 2015, 15, 763-772..